CIK 0001802369 · <br>Emerging growth company
ADARx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ADRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844145188
- Phone
- 858-283-9472
- Business address
- 5871 OBERLIN DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $87,745,772
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$87,745,772. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-28 | Chimovits Erez Director | Purchase | +61,516 | $17.00 | $1.0M | 9,292,025 |
| 2026-09-28 | GORDON CARL L Director | Purchase | +300,249 | $17.00 | $5.1M | 14,325,529 |
| 2026-09-28 | GORDON CARL L Director | Purchase | +61,516 | $17.00 | $1.0M | 9,292,025 |
| 2026-09-28 | GORDON CARL L Director | Purchase | +588,235 | $17.00 | $10.0M | 588,235 |
| 2026-09-28 | ORBIMED ADVISORS LLC Director | Purchase | +300,249 | $17.00 | $5.1M | 14,325,529 |
| 2026-09-28 | ORBIMED ADVISORS LLC Director | Purchase | +61,516 | $17.00 | $1.0M | 9,292,025 |
| 2026-09-28 | ORBIMED ADVISORS LLC Director | Purchase | +588,235 | $17.00 | $10.0M | 588,235 |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +592,593 | $17.00 | $10.1M | 5,554,094 |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +414,814 | $17.00 | $7.1M | 1,953,505 |
| 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +592,593 | $17.00 | $10.1M | 592,593 |
| 2026-09-28 | George Simeon Director | Purchase | +592,593 | $17.00 | $10.1M | 5,554,094 |
| 2026-09-28 | George Simeon Director | Purchase | +414,814 | $17.00 | $7.1M | 1,953,505 |
| 2026-09-28 | George Simeon Director | Purchase | +592,593 | $17.00 | $10.1M | 592,593 |
Page 1 of 1 · 13 trades